期刊文献+

增生性瘢痕和瘢痕疙瘩p53基因多态性的分析 被引量:26

Investigation of p53 polymorphism for genetic predisposition of keloid and hypertrophic scar
原文传递
导出
摘要 目的 探讨p5 3基因codon 72部位的多态性分布是否与增生性瘢痕及瘢痕疙瘩的易发性有关。方法 以日本医科大学整形外科行手术治疗患者的切除瘢痕标本为材料 ,利用限制性片段长度多态性分析法 (RFLP)及DNA序列分析法 (DNA sequence) ,对 5 4例瘢痕疙瘩标本和 30例增生性瘢痕标本的p5 3基因codon 72部位编码精氨酸 (Arg)和脯氨酸 (Pro)的等位基因CGC(Arg)和CCC(Pro)进行了分析。结果 与正常日本人群外周血p5 3基因codon 72部位的多态性频度分布相比 ,瘢痕疙瘩差异无显著性 ,而增生性瘢痕则差异有显著性。此外 ,由穿耳孔所致的耳部瘢痕疙瘩CGC(Arg)基因型显著增高。结论 推测p5 3codon 72部位具有CGC CGC (Arg Arg)纯合型者耳部瘢痕疙瘩的发生率明显增高 ,具有CCC CCC (pro pro)纯合型者增生性瘢痕发生率增高。 Objective To investigate the codon |72 polymorphism of the tumor suppressor gene p53,codon |72 encodes arginine(Arg)or proline(Pro)for a genetic predisposition to keloid or hypertrophic scar. Methods The distribution of codon 72 polymorphism of p53 gene was analyzed from the 54 keloid and 30 hypertrophic scar(HS)of the Japanese patients with restriction fragment length polymorphism analysis and DNA sequence analysis. Results The frequency of the Proline |encoding alleles and Arginine |encoding alleles in the hypertrophic scar patients and the piercing |induced ear |lobe keloid patients,was deviated significantly from that in the normal Japanese controls. Conclusions The Proline |encoding allele and Arginine |encoding allele could have the risks for the hypertrophic scar and the piecing |induced ear |lobe keloid.Also,the pathogenesis of the hypertrophic scar seems to be different from that of keloid at the molecular level. ;
出处 《中华整形外科杂志》 CAS CSCD 北大核心 2005年第1期32-35,共4页 Chinese Journal of Plastic Surgery
关键词 增生性瘢痕 瘢痕疙瘩 P53 基因多态性 Keloid Hypertrophic scar p53 codon-72 RFLP Genetic polymorphism
  • 引文网络
  • 相关文献

参考文献15

  • 1Alhady SMA, Sivanan TK. Keloids in various races: a review of 175 cases. Plast Reconstr Surg, 1969,44:564-566.
  • 2Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1000patients with keloids in South India. Plast Reconstr Surg, 1974,53:276-280.
  • 3Levine AJ. p53, the cellular gatekeeper for growth and division. Cell,1997,88:323-331.
  • 4Balmain A, Harris CC. Carcinogenesis in mouse and human cells:parallels and paradoxes. Carcinogenesis, 2000,21: 371-377.
  • 5Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 1993,262:1980-1982.
  • 6Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered, 1994,44: 266-270.
  • 7Yu MW, Yang SY, Chiu YH, et al. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.Hepatology, 1999,29: 697-702.
  • 8Oura T, Sugihara H, Yoshida T. The definition and clinical classification of keloids and hypertrophic scars. Japan J Plast Reconstr Surg, 1993,36: 265-274.
  • 9Sugano K, Nakashima Y, Yamaguchi K, et al. Sensitive detection of loss of heterozygosity in the Tp53 gene in pancreatic adenocarcinoma by fluorescence-based single-strand conformation polymorphism analysis using blunt-end DNA fragments. Genes Chromosomes Cancer, 1996,15:157-164.
  • 10Murata M, Tagawa M, Kimura M, et al. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis, 1996,17: 261-264.

同被引文献296

引证文献26

二级引证文献104

;
使用帮助 返回顶部